*Nobuhisa Kanahara1,13, Kazuki Okada2, Yuji Otsuka3, Remiko Kobayashi2, Hiroshi Kimura4, Hiroshi Yamanaka5, Yuri Takaoki6, Taisuke Yoshida7, Takahiro Oiwa8, Fumiaki Ito9, Hiroshi Komatsu10, Takashi Ono11, Yuki Kikuchi12, Takahisa Saiga6, Shingo Noda13, Masaomi Iyo2
(1. Chiba University Center for Forensic Mental Health, Chiba, Japan, 2. Department of Psychiatry, Chiba University Graduate School of Medicine, Chiba, Japan, 3. Department of Psychiatry, Asahi General Hospital, Asahi, Japan, 4. Department of Psychiatry, Gakuji-kai Kimura Hospital, Chiba, Japan, 5. Department of Psychiatry, Chiba Psychiatric Medical Center, Chiba, Japan, 6. Department of Psychiatry, Japanese Red Cross Narita Hospital, Narita, Japan, 7. Department of Psychiatry, Doujin-kai Kisarazu Hospital, Kisarazu, Japan, 8. Department of Psychiatry, Naoki-kai Isogaya Hospital, Ichihara, Japan, 9. Department of Psychiatry, National Hospital Organization Hanamaki Hospital, Hanamaki, Japan, 10. Department of Psychiatry, Tohoku University Hospital, Sendai, Japan, 11. Department of Psychiatry, Miyagi Psychiatric Center, Natori, Japan, 12. Department of Psychiatry, Yukou-kai, Kodama Hospital, Ishinomaki, Japan, 13. Department of Psychiatry, Ichihara-Tsuruoka Hospital, Ichihara, Japan)
Keywords:Treatment-resistant schizophrenia, Clozapine, Antipsychotic, Dopamine supersensitivity, Treatment response
Abstract password authentication.
Password is required to view the abstract. Please enter a password to authenticate.